Regeneron Pharmaceuticals logo
Regeneron Pharmaceuticals REGN
$ 828.84 -1.75%

Quarterly report 2024-Q3
added 10-31-2024

report update icon

Regeneron Pharmaceuticals Total Current Liabilities 2011-2024 | REGN

Annual Total Current Liabilities Regeneron Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
3.42 B 3.14 B 3.93 B 2.7 B 2.1 B 1.44 B 1.14 B 1.24 B 811 M 655 M 299 M 164 M 148 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
3.93 B 148 M 1.63 B